Related Experiment Video
Updated: Jul 6, 2026
10:03
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
5.3K
Prognostic Biomarkers Based on Proteomic Technology in COPD: A Recent Review
Hanyu Fang1, Ying Liu2, Qiwen Yang1
1Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China.
Summary
This review explores proteomic biomarkers for predicting Chronic Obstructive Pulmonary Disease (COPD) prognosis. It highlights omics technologies
Area of Science:
- Pulmonary Medicine and Omics Technologies
Background:
- Chronic Obstructive Pulmonary Disease (COPD) is a complex respiratory condition with airflow limitation.
- Heterogeneity and phenotypic complexity of COPD challenge traditional diagnostic and management approaches.
- Omics technologies (proteomics, metabolomics, transcriptomics) offer new avenues for COPD research.
Purpose of the Study:
- To review and summarize prognostic biomarkers for COPD identified through proteomic studies.
- To evaluate the association between these proteomic biomarkers and COPD prognosis.
- To discuss future prospects and challenges in COPD prognostic biomarker research.
Main Methods:
- Literature review focusing on recent proteomic studies related to COPD prognosis.
- Analysis and synthesis of identified prognostic biomarkers from proteomic data.
- Evaluation of the clinical relevance and association of biomarkers with COPD outcomes.
Main Results:
- Proteomic studies have identified several potential biomarkers associated with COPD prognosis.
- These biomarkers offer insights into the underlying mechanisms and heterogeneity of COPD.
- The review consolidates current knowledge on proteomic prognostic markers for COPD.
Conclusions:
- Proteomic biomarkers show promise for improving prognostic evaluation in clinical COPD management.
- Further research is needed to validate these biomarkers and address existing challenges.
- Omics-driven approaches are crucial for advancing our understanding and treatment of COPD.
More Related Videos
Related Concept Videos
01:33Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.